HIV and tuberculosis co-infection in an Inner London hospital - A prospective anonymized seroprevalence study

Journal of Infection

Volumn 38, Issue 3, 1999, Pages 162-166

  Marshall, Ben G ^a   Mitchell, David M ^a   Shaw, Rory J ^a   Marais, Frederick ^a   Watkins, Ruth M ^a   Coker, Richard J ^a  

^a IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; CHILD; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; SCHOOL CHILD; TUBERCULOSIS; UNITED KINGDOM;

EID: 0032979255     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-4453(99)90244-X     Document Type: Article

References (29)

1. Hayward AC, Watson JM. Tuberculosis in England and Wales 1982-1993: notifications exceeded predictions. CDR 1995; 5: RR29-RR33.
2. Pearson A, Hamilton G, Healing T, Maguire H, Feltham R. The surveillance, prevention and control of tuberculosis in London. London: 1995. The report of the Working Group on Tuberculosis of the London Group of Consultants in Communicable Disease Control.
3. Hayward A. Tuberculosis control in London: the need for change. A report for the Thames Regional Directors of Public Health (A discussion document). London: NHS Executive, 1998.
4. Office of population censuses and surveys, communicable disease surveillance centre. communicable disease statistics, England and Wales, 1992. London: HMSO, 1994.
5. Anon. Tuberculosis in 1993: preliminary results of national survey. CDR 1994; 4: 235.
6. Watson JM. Results of a national survey of tuberculosis notifications in England and Wales in 1993. Thorax 1995: 50: 442.
7. Kumar D, Watson J, Charlett A, Nicholas S, Darbyshire J. Tuberculosis in England and Wales in 1993: results of a national survey. Thorax 1997; 52: 1060-1067.
8. Jereb J, Kelly G, Dooley SJ, Cauthen G, Snider D. Tuberculosis morbidity in the United States: final data. 1990; MMWR 1990; 3: 23-27.
9. Brudney K, Dobkin J. Resurgent tuberculosis in New York City: human immunodeficiency virus, homelessness and the decline of tuberculosis control programmes. Am Rev Respir Dis 1991; 144: 745-749.
10. Frieden TR, Fujiwara PI, Washko RM, Hamburg MA. Tuberculosis in New York City-turning the tide. N Engl J Med 1995: 333: 229-233.
11. TB - a global emergency. WHO report on the TB epidemic. Geneva, 1994: World Health Organisation 1994.
12. Lucas S, Nelson A. Pathogenesis of tuberculosis in human immunodeficiency virus-infected people. In: Bloom B, ed. Tuberculosis: pathogenesis, protection and control. Washington DC: ASM Press, 1994: 503-513.
13. Selwyn PA, Hartel D, Lewis VA. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 1989; 320: 545-550.
14. Watson JM, Meredith SK, Whitmore-Overton E, Bannister B, Darbyshire JH. Tuberculosis and HIV: estimates of the overlap in England and Wales. Thorax 1993; 48: 199-203.
15. The interdepartmental Working Group on Tuberculosis. The prevention and control of tuberculosis in the United Kingdom: recommendations for the prevention and control of tuberculosis at local level. London: Department of Health, 1996.
16. Taylor I, Evans D, Coker R, Mitchell D, Shaw R. Mycobacterial infection in HIV seropositive and seronegative populations, 1987-1993. Thorax 1995; 50: 1147-1150.
17. Maguire H, Holland R, Pankhania B. Molecular epidemiology of tuberculosis in London 1995 and 1996. 23rd PHLS Annual Scientific Conference. September, 1998.
18. Greenberg B, Weisfuse I, Makki H, Adler J, El Sadr W, Clarke L. HIV-1 seroprevalence in chest linic and hospital tuberculosis patients in New York City 1989-1991. AIDS 1994; 8: 957-962.
19. Hayward AC, Goss S, Drobniewski F. Molecular epidemiology of tuberculosis in London. British Thoracic Society Winter Conference. 1997.
20. Poznansky M, Coker RJ, Skinner C. HIV positive patients first presenting with an AIDS defining illness: characteristics and survival. Br Med J 1995; 311: 156-158.
21. Goletti D, Weissman D, Jackson R, Graham N, Vlahov D, Klein R. Effect of Mycobacterium tuberculosis on HIV replication: role of immune activation. J Immunol 1996; 157: 1271-1278.
22. Joint Tuberculosis Committee of the British Thoracic Society. Control and prevention of tuberculosis in the United Kingdom: code of practice 1994. Thorax 1994; 49: 1193-1200.
23. Palella Jr FJ, Delaney KM, Moorman AC. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998; 338: 853-860.
24. Del Amo J. Petruckevitch A. Phillips AN. Spectrum of disease in Africans with AIDS in London. AIDS 1996; 10: 1563-1569.
25. Landau R, Coker RJ, Weber J, Touquet R, Fothergill J, Poznansky MC. Patients unaware of their HIV status present to an inner-city accident and emegency department with respiratory complications. J Acc Emerg Med 1997; 14: 304-6.
26. Horner P, McBride M, Coker R. Outpatient followup in women with HIV infection in Parkside Health Authority. Genitourin Med 1993; 69: 370-372.
27. Shaw R, Coker RJ. Tuberculosis and the acquired immunodeficiency syndrome. In: Gangadharam PRJ, Jenkins PA. eds. Mycobacteria. Vol. 2. New York: Chapman & Hall 1997: 209-235.
28. Churchill DR, Harman M, Miller RF, et al. HIV-associated tuberculosis is increasing in north London. 75th Medical Society for the Study of Venereal Diseases. Oxford, July 1997 [Abstract 40].
29. de Cock K, Low N. HIV and AIDS, other sexually transmitted diseases, and tuberculosis in ethnic minorities in the United Kingdom: is surveillance serving its purpose? Br Med J 1997; 314: 1747-1750.